Advertisement
Advertisement
Myotec

Myotec Special Precautions

mycophenolic acid

Manufacturer:

United Biotech

Distributor:

Triple Tact

Marketer:

A-Z Med Inc
Full Prescribing Info
Special Precautions
General: Gastrointestinal bleeding has been observed in approximately 3% of renal, in 1.7% of cardiac, and in 5.4% of hepatic transplant patients treated with mycophenolate mofetil 3 g daily.
During treatment with mycophenolate mofetil, the use of live attenuated vaccines should be avoided and patients should be advised that vaccinations may be less effective.
Complete blood counts should be performed weekly during the first month, twice monthly for the second and third months of treatment, then monthly through the first year.
Use in Pregnancy: Teratogenic Effects: Pregnancy Category D. See Warnings.
Use in Lactation: Studies in rats treated with mycophenolate mofetil have shown mycophenolic acid to be excreted in milk. It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, and because of the potential for serious adverse reactions in nursing infants from mycophenolate mofetil, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.
Use in Children: Based on pharmacokinetic and safety data in pediatric patients after renal transplantation, the recommended dose of mycophenolate mofetil is 600 mg/m2 bid (up to a maximum of 1 g bid). Safety and effectiveness in pediatric patients receiving allogeneic cardiac or hepatic transplants have not been established.
Use in Elderly: Clinical studies of mycophenolate mofetil did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between the elderly and younger patients. In general dose selection for an elderly patient should be cautious, reflecting the greater frequency of decreased hepatic, renal or cardiac function and of concomitant or other drug therapy. Elderly patients may be at an increased risk of adverse reactions compared with younger individuals.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement